跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MEZINC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MEZINC
Authorized
STANDARD
MEZINC
Abigo Medical AB
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
31cb1c41b6614179
Company
Abigo Medical AB
Type
Standard
Approval Details
Approval Id
31cb1c41b6614179
Drug Approval Canada Name
MEZINC
Product Name
MEZINC
Status
Cancelled Pre Market
Status Date
2017-12-02
Din
02240126
Drug Class
Human
Dosage Form
Plaster
Route Of Administration
Topical
Aig Number
0106504017
Company Name
Abigo Medical AB
Company Address
Datavägen 29, Askim, --, Sweden, 43632
Company Detail Path
/organization/abigo-medical-ab
Company Information
Pharmaceutical Company Name
Abigo Medical AB
Country Name
Sweden
Province Name
västra götaland,country_se
City Name
askim,västra götaland,country_se
Address
Ekonomivägen 5
Active Ingredients
ZINC OXIDE
28.3 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
31cb1c41b6614179
Type
Standard
Back to Health Canada Approvals